Enliven Therapeutics Return on Net Operating Assets Insights

Enliven Therapeutics, Inc. (ELVN)

38.83 +1.04 (+2.75%) USD | NASDAQ | Apr 02, 16:00

38.72 -0.11 (-0.28%) After-Hours: 20:00

View Return on Net Operating Assets for ELVN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	Upgrade
Sarepta Therapeutics, Inc.	Upgrade
Coherus Oncology, Inc.	Upgrade
Kodiak Sciences, Inc.	Upgrade
Allogene Therapeutics, Inc.	Upgrade